GW873140 In Combination With Combivir In HIV Infected Subjects

NCT00104429 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Infection, Human Immunodeficiency Virus I
HIV Infection

Interventions

DRUG: GW873140
DRUG: Combivir

Sponsor

ViiV Healthcare